Is Sjögren myelopathy Devic disease?

Annals of the Rheumatic Diseases

Volumn 67, Issue 5, 2008, Pages 730-731

  Sofat, N ^a   Venables, P J ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; OLIGOCLONAL BAND; PHOSPHOLIPID DERIVATIVE; STEROID;

AGED; ANAMNESIS; BRAIN DAMAGE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CONVALESCENCE; DISEASE ASSOCIATION; FEMALE; HUMAN; LETTER; LUMBAR PUNCTURE; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NEURITIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; QUESTIONNAIRE; SJOEGREN SYNDROME; SPINAL CORD; SPINAL CORD DISEASE; SWELLING; WHITE MATTER; BLOOD; CLASSIFICATION; IMMUNOLOGY; PATHOLOGY;

AGED; FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA; SJOGREN'S SYNDROME; SPINAL CORD;

EID: 42449099325     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.077883     Document Type: Letter

References (10)

1. Alexander EL, Malinow K, Lejewski JE, Jerdan MS, Provost TT, Alexander GE. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis. Ann Int Med 1986;104:323-30.
2. Wright RA, O'Duffy JD, Rodriguez M. Improvement of myelopathy in Sjögren's syndrome with chlorambucil and prednisone therapy. Neurology 1999;52:386-8.
3. Vincent TL, Richardson MP, Mackworth-Young CG, Hawke, Venables PJW. Sjögren's syndrome-associated myelopathy: response to immunosuppressive treatment. Am J Med 2003;114:145-8.
4. Sofat N, Malik O, Higgens CS. Neurological involvement in patients with rheumatic disease. QJM 2006;99:69-79.
5. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999;53:1107-14.
6. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66:1485-9.
7. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004;364:210-12.
8. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. European Study Group on Classification Criteria for Sjögren's Syndrome. Ann Rheum Dis 2002;61:554-8.
9. Okai AF, Muppidi S, Bagla R, Leist TP. Progressive necrotizing myelopathy: part of the spectrum of neuromyelitis optica? Neurol Res 2006;28:354-9.
10. Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004;83:280-91.